Lilly (LLY.US) has already splurged over $20 billion this year! CEO: Will target pharmaceutical "white spaces" and continue to pursue larger-scale M&A.

Zhito Finance APP has learned that Eli Lilly (LLY.US) CEO Dave Ricks said investors can expect the company to pursue larger deals, similar to its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as the company conducts a broad search for assets in "white space" areas of science.